Advertisement
Research ArticleNeuropharmacology

Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine

Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-ichi Yamaguchi, Kenji Hashimoto and Shigeyuki Chaki
Journal of Pharmacology and Experimental Therapeutics April 2017, 361 (1) 9-16; DOI: https://doi.org/10.1124/jpet.116.239228

Article Information

vol. 361 no. 1 9-16
DOI 
https://doi.org/10.1124/jpet.116.239228
PubMed 
28115553
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received November 24, 2016
  • Accepted January 18, 2017
  • Published online February 27, 2017.

Article Versions

Copyright & Usage 
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kenichi Fukumoto,
  2. Hidetoh Toki,
  3. Michihiko Iijima,
  4. Takashi Hashihayata,
  5. Jun-ichi Yamaguchi,
  6. Kenji Hashimoto, and
  7. Shigeyuki Chaki
  1. Research Headquarters, Taisho Pharmaceutical Co., Ltd., Saitama, Japan (K.F., H.T., M.I., T.H., J.Y., S.C.); and Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan (K.H.)
  1. Address correspondence to:
    Dr. Shigeyuki Chaki, Research Headquarters, Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama, Japan. E-mail: s-chaki{at}so.taisho.co.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2017 to June 2023

AbstractFullPdf
Jan 20172640146
Feb 201732016190
Mar 2017394138158
Apr 20172315866
May 2017887773
Jun 2017774957
Jul 2017834355
Aug 2017633548
Sep 20171053656
Oct 2017704834
Nov 2017624939
Dec 2017812747
Jan 2018914537
Feb 2018903838
Mar 201867544
Apr 201837854
May 201827148
Jun 201846531
Jul 201807049
Aug 201807444
Sep 201827453
Oct 2018012143
Nov 2018211753
Dec 201807642
Jan 201968147
Feb 20191610058
Mar 20192115267
Apr 2019207977
May 2019208759
Jun 2019137170
Jul 20191687104
Aug 2019147792
Sep 201988388
Oct 201910106143
Nov 2019329345
Dec 2019118046
Jan 20202011465
Feb 20201710363
Mar 2020127662
Apr 2020119160
May 20208011748
Jun 20203598132
Jul 2020228855
Aug 2020246057
Sep 2020207872
Oct 20203518649
Nov 20202326455
Dec 20202731545
Jan 20214310156
Feb 2021458764
Mar 2021468684
Apr 2021307570
May 2021306040
Jun 2021236628
Jul 2021348736
Aug 2021136930
Sep 2021257535
Oct 20213911666
Nov 2021389953
Dec 2021256433
Jan 20223611158
Feb 2022368240
Mar 2022419647
Apr 2022498853
May 20224110566
Jun 2022229339
Jul 2022289436
Aug 2022238433
Sep 2022219452
Oct 2022289336
Nov 20223117181
Dec 2022469850
Jan 2023409639
Feb 2023508933
Mar 20232092422
Apr 20231641313
May 20231221314
Jun 2023520

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleNeuropharmacology

Antidepressant Effects of (R)-Ketamine

Kenichi Fukumoto, Hidetoh Toki, Michihiko Iijima, Takashi Hashihayata, Jun-ichi Yamaguchi, Kenji Hashimoto and Shigeyuki Chaki
Journal of Pharmacology and Experimental Therapeutics April 1, 2017, 361 (1) 9-16; DOI: https://doi.org/10.1124/jpet.116.239228
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement